IP3R Modulation by Cancer Genes in Mesothelioma

Clinical trial NCT03558932 · UNKNOWN

Trial details

NCT number: NCT03558932
Sponsor: KU Leuven
Status: UNKNOWN
Study type: OBSERVATIONAL

Malignant Mesothelioma

Start date: 2019-01-01
Primary completion: 2023-12-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.